Pharma Reimbursement & Market Access

Date: 24-Mar-15 to 25-Mar-15
Location: Boston Marriott Burlington / Boston / Massachusetts / United States
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

Patent expirations, the availability of generics and biosimilars have changed. This strategy meeting will cover the key topics that are the drivers behind the issues that we face.

Visitors

Attendees will
*Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer’s overall market access strategy
*Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
*Examine how to use HTA to create payer evidence: The role of postapproval programs
*Learn key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
*Examine the evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
*Gain insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
*Anticipate the implementation of ICD-10 and the underlying effect on product access
*Analyze the current state of affairs: Post midterm elections in the exchange marketplace and the impact on drug positioning
*Determine your engagement model: The new look of pharma/ biopharma/payer relationship

Exhibitors

Your speakers:
- Andrew Storey
Abbvie
United States
VP
- Stacie Maass
American Pharmacist
United States
SVP Government Affairs
- Oved Amitay
Alnylam Pharma
United States
Vice President
...see the full speaker list on our website

Go to event website